The Scientific Programme will deal with most recent developments in autologous and allogeneic transplantation. Transplant will be viewed not as a stand-alone procedure, but as a part of a complex therapeutic program that includes molecularly targeted drugs, supportive therapies, cell selection, and gene-modified cell therapies.
The key message will be the integration among top level science, high technology (particularly cell and gene therapy), and clinical excellence.
From: March 30, 2014 10:00
To: April 02, 2014 13:15
MiCo - Milano Congressi, Piazzale Carlo Magno, 20149, Milan, IT